Denmark· DK-28103763404
Finigen
A terbinafine product containing terbinafinhydrochlorid, registered in Denmark by Orifarm Generics A/S. The same ATC class is registered in 12 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Terbinafine is registered in 12 of 19 countries.
Countries holding a registration under ATC D01AE15 (terbinafine), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 7 of them publish a price we can compare per daily dose
Terbinafine · ATC D01AE15
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of terbinafine costs, country by country.
Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Terbinafine · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.14
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- TERBINAFINHYDROCHLORID
- Manufacturer
- Orifarm Generics A/S
- Country
- Denmark (DK)
- ATC code
- D01AE15
- ATC class
- Terbinafine
- Defined daily dose
- 10 mg, T
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28103763404
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
359 interactions on record for terbinafine.
Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Terbinafine · interactions on record
359 records
- 16 severe
- 128 moderate
- 11 minor
- 202 info
Most severe, free to view
- EliglustatA16AX10severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- PexidartinibL01EX15severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under D01AE15
Terbinafine, as other registers publish it.
- NetherlandsAntischimmelcrème HTP Terbinafine HCl 10 mg/g, crèmeHealthypharm B.V.
- NetherlandsBinanidda 1% creme, creme 10 mg/gratiopharm GmbH
- NetherlandsDA Antischimmelcrème Terbinafine HCl 10 mg/g, crèmeNederlandse Drogisterij Service B.V.
- NetherlandsEtos Huidschimmelcrème terbinafine HCl 10 mg/g, crèmeHealthypharm B.V.
- SwitzerlandFung-X Derma, Crèmeaxapharm ag
- SwitzerlandFung-X Derma, Crèmeaxapharm ag
- SwitzerlandFung-X Derma, Crèmeaxapharm ag
- FinlandFungisSandoz A/S
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f46cd32a-5d92-4e41-b564-7062eca9b8a4 GET /v1/drugs/f46cd32a-5d92-4e41-b564-7062eca9b8a4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "creme",
"source": "dkma",
"strength": "10 mg/g",
"auth_role": "DKMA",
"dk_drugid": "28103763404",
"substance": "TERBINAFINHYDROCHLORID",
"auth_procedure": "National",
"in_medicinpriser": true,
"registration_date_serial": "39183"
}See everything about terbinafine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.